Search Results - Visanji, N.P.

  • Showing 1 - 3 results of 3
Refine Results
  1. 1
    Nicotine, but neither the α4β2 ligand RJR2403 nor an α7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle

    Nicotine, but neither the α4β2 ligand RJR2403 nor an α7 nAChR subtype selective agonist, protects against a partial 6-hydroxydopamine lesion of the rat median forebrain bundle by Visanji, N.P., O'Neill, M.J., Duty, S.

    Published in Neuropharmacology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  2. 2
    Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and α6 and β3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat

    Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and α6 and β3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars comp... by Visanji, N.P., Mitchell, S.N., O'Neill, M.J., Duty, S.

    Published in Neuropharmacology
    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and α 6 and β 3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars compacta of the rat

    Chronic pre-treatment with nicotine enhances nicotine-evoked striatal dopamine release and α 6 and β 3 nicotinic acetylcholine receptor subunit mRNA in the substantia nigra pars co... by Visanji, N.P., Mitchell, S.N., O'Neill, M.J., Duty, S.

    Published in Neuropharmacology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: